Shanghai Sanyou Medical Co., Ltd. (Stock Code: 688085) (“Sanyou”), restructured in 2011 and listed on the STAR Market in 2020, is a high-tech orthopedic medical device enterprise and China’s benchmark for clinically driven original innovation in the orthopedic implant sector. 

In 2022, Shanghai Sanyou Medical Instruments Co., Ltd. chose SIPM/PLM to raise the standard of its R&D management. Through SIPM's professional services experience, data standardisation no longer has to start from scratch: the company can stand directly on the shoulders of others, avoid duplicated effort, see further ahead and move better and farther. The R&D management philosophy that SIPM/PLM applies between design and production reflects precisely the completeness of Sanyou Medical's thinking on enterprise informatisation, providing substantial support for organisational growth. SIPM's professional services team continues to spare no effort in giving Sanyou Medical's enterprise data governance complete support and assurance as long-term, routine foundational work.

As its R&D team keeps growing and the application of SIPM/PLM keeps deepening, and in order to ensure that day-to-day R&D work proceeds efficiently and in good order, Sanyou Medical recently signed an additional purchase contract for the SIPM/PLM system with SIPM Software, increasing the number of concurrent users on the PLM system.

【Company Background】

Shanghai Sanyou Medical Co., Ltd. (Stock Code: 688085) (“Sanyou”), restructured in 2011 and listed on the STAR Market in 2020, is a high-tech orthopedic medical device enterprise and China’s benchmark for clinically driven original innovation in the orthopedic implant sector. 

Sanyou features a product portfolio covering the full spectrum of orthopedic clinical demands. Its group-wide strategy centers on four core pillars: Orthopedic Solutions, Active Devices, Biomaterials & Regenerative Medicine, and Emerging Technologies. With a controlling stake in France’s Implanet, Sanyou has established a strong presence in Europe and beyond. It operates a nationally accredited CNAS laboratory and holds more than 600 patents, underpinning its long-term sustainability.